LEMAITRE VASCULAR, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
LEMAITRE VASCULAR, INC. (LMAT) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 21.18 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2025-02-28
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2022-03-31 was 112.00 shares, a 83.86% decline year-over-year.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2021-09-30 was 0.00 shares.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2021-06-30 was 463.00 shares, a 141.15% increase year-over-year.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2021-03-31 was 694.00 shares, a 66.95% decline year-over-year.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2024 was 21.18K shares, a 21.21% decline from fiscal 2023.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2023 was 26.88K shares.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2017 was 67.52K shares, a 47.64% decline from fiscal 2016.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2016 was 128.95K shares, a 104.87% increase from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2024-12-31 | 21.18K shares 10-K · filed 2025-02-28 | |||
| 2023-12-31 | 26.88K shares 10-K · filed 2024-02-29 | |||
| 2022-03-31 | 112.00 shares 10-Q · filed 2022-05-10 | |||
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 463.00 shares derived: sum of 2 quarters · filed 2021-11-04 | 1.16K shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 463.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 1.16K shares 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | 694.00 shares 10-Q · filed 2022-05-10 | |||
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 192.00 shares derived: sum of 2 quarters · filed 2021-11-04 | 2.29K shares 10-Q · filed 2021-11-04 | |
| 2020-06-30 | 192.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 2.29K shares 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | 2.10K shares 10-Q · filed 2021-05-10 | |||
| 2017-12-31 | 67.52K shares 10-K · filed 2018-03-09 | |||
| 2016-12-31 | 128.95K shares 10-K · filed 2017-03-09 | |||
| 2015-12-31 | 62.94K shares 10-K · filed 2016-03-10 | |||
| 2014-12-31 | 84.34K shares 10-K · filed 2015-03-18 | |||
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 0.00 shares 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | 0.00 shares 10-Q · filed 2015-05-07 | |||
| 2013-12-31 | 117.87K shares 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |